Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block
Jun Sung Moon (Moon JS), Kyu Chang Won (Won KC)
Diabetes Metab J. 2015;39(1):1-9.   Published online 2015 Feb 16     DOI:
Citations to this article as recorded by Crossref logo
The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
Soyeon Yoo, Dongkyu Kim, Gwanpyo Koh
Journal of Clinical Medicine.2021; 10(11): 2487.     CrossRef
Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
Hong Wang, Jie Cao, Jian-bin Su, Xue-qin Wang, Xing Wang, Dong-mei Zhang, Xiao-hua Wang
Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
Angiopoietins stimulate pancreatic islet development from stem cells
Soujanya S. Karanth, Shuofei Sun, Huanjing Bi, Kaiming Ye, Sha Jin
Scientific Reports.2021;[Epub]     CrossRef
A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 3567.     CrossRef
The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror
María Sofía Martínez, Alexander Manzano, Luis Carlos Olivar, Manuel Nava, Juan Salazar, Luis D’Marco, Rina Ortiz, Maricarmen Chacín, Marion Guerrero-Wyss, Mayela Cabrera de Bravo, Clímaco Cano, Valmore Bermúdez, Lisse Angarita
International Journal of Molecular Sciences.2021; 22(17): 9504.     CrossRef
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s
William T. Cefalu, Dana K. Andersen, Guillermo Arreaza-Rubín, Christopher L. Pin, Sheryl Sato, C. Bruce Verchere, Minna Woo, Norman D. Rosenblum
Canadian Journal of Diabetes.2021;[Epub]     CrossRef
The role of GIP in α-cells and glucagon secretion
Kimberley El, Jonathan E. Campbell
Peptides.2020; 125: 170213.     CrossRef
Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetes
Muhammad Yazid Jalaludin, Margarita Barrientos-Pérez, Mona Hafez, Jane Lynch, Naim Shehadeh, Serap Turan, Daniel Weghuber
Clinical Trials.2020; 17(1): 87.     CrossRef
Recent advances in understanding the role of glucagon-like peptide 1
Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi
F1000Research.2020; 9: 239.     CrossRef
Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study
Irene Roncero-Ramos, Juan F. Alcala-Diaz, Oriol A. Rangel-Zuñiga, Francisco Gomez-Delgado, Rosa Jimenez-Lucena, Antonio García-Rios, Cristina Vals-Delgado, Cristina Romero-Baldonado, Raul M. Luque, Jose M. Ordovas, Pablo Perez-Martinez, Antonio Camargo, J
Clinical Nutrition.2020; 39(2): 492.     CrossRef
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)
Soo Heon Kwak, You‐Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang‐Yong Kim, Jae Hyeon Kim
Diabetes, Obesity and Metabolism.2020; 22(2): 173.     CrossRef
Pathophysiology of Type 2 Diabetes in Children and Adolescents
Badhma Valaiyapathi, Barbara Gower , Ambika P. Ashraf
Current Diabetes Reviews.2020; 16(3): 220.     CrossRef
Decellularized Tissue Matrix Enhances Self-Assembly of Islet Organoids from Pluripotent Stem Cell Differentiation
Huanjing Bi, Soujanya S. Karanth, Kaiming Ye, Roland Stein, Sha Jin
ACS Biomaterials Science & Engineering.2020; 6(7): 4155.     CrossRef
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
Dipeeka K. Mandaliya, Sriram Seshadri
Pancreatology.2019; 19(4): 617.     CrossRef
A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia
Sushil Kumar Sah, Vijaya Paul Samuel, Sunita Dahiya, Yogendar Singh, Ritu M. Gilhotra, Gaurav Gupta, Anurag Mishra, Rakesh Kumar Sharma, Gubbiyappa Shiva Kumar, Nagaraja SreeHarsha, Dinesh Kumar Chellappan, Kamal Dua
Chemico-Biological Interactions.2019; 306: 117.     CrossRef
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
Dipeeka K. Mandaliya, Sriram Seshadri
Pancreatology.2019; 19(2): 280.     CrossRef
Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients
Minyoung Lee, Minkyung Kim, Jong Suk Park, Sangbae Lee, Jihong You, Chul Woo Ahn, Kyung Rae Kim, Shinae Kang
The Korean Journal of Internal Medicine.2019; 34(5): 1068.     CrossRef
Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells
Pan Liu, Jia Song, He Liu, Fei Yan, Tianyi He, Lingshu Wang, Huying Shen, Xinguo Hou, Li Chen
Endocrine.2018; 62(2): 394.     CrossRef
Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential
Ana Marta de Matos, Maria Paula de Macedo, Amélia Pilar Rauter
Medicinal Research Reviews.2018; 38(1): 261.     CrossRef
Alpha cell function interacts with diet to modulate prediabetes and Type 2 diabetes
Irene Roncero-Ramos, Rosa Jimenez-Lucena, Juan F. Alcala-Diaz, Cristina Vals-Delgado, Antonio P. Arenas-Larriva, Oriol A. Rangel-Zuñiga, Ana Leon-Acuña, María M. Malagon, Javier Delgado-Lista, Pablo Perez-Martinez, Jose M. Ordovas, Antonio Camargo, Jose L
The Journal of Nutritional Biochemistry.2018; 62: 247.     CrossRef
Targetting PED/PEA-15 for diabetes treatment
Francesca Fiory, Rosa Spinelli, Gregory Alexander Raciti, Luca Parrillo, Vittoria D’esposito, Pietro Formisano, Claudia Miele, Francesco Beguinot
Expert Opinion on Therapeutic Targets.2017; 21(6): 571.     CrossRef
Butungeshwar Pradhan, Chakradhar Majhi
Journal of Evidence Based Medicine and Healthcare.2017; 4(45): 2775.     CrossRef
Glucagon and heart in type 2 diabetes: new perspectives
Antonio Ceriello, Stefano Genovese, Edoardo Mannucci, Edoardo Gronda
Cardiovascular Diabetology.2016;[Epub]     CrossRef
Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes
Sivaram Pillarisetti
Trends in Pharmacological Sciences.2016; 37(3): 207.     CrossRef
The biology of glucagon and the consequences of hyperglucagonemia
Nicolai J Wewer Albrechtsen, Rune E Kuhre, Jens Pedersen, Filip K Knop, Jens J Holst
Biomarkers in Medicine.2016; 10(11): 1141.     CrossRef
Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?
Chloé Amouyal, Fabrizio Andreelli
Journal of Diabetes Research.2016; 2016: 1.     CrossRef
Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1
Toya M Albury-Warren, Veethika Pandey, Lina P Spinel, Michal M Masternak, Deborah A Altomare
Journal of Endocrinology.2016; 228(1): 49.     CrossRef
Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin
Hao Liu, Yun Hu, Feng-fei Li, Bing-li Liu, Xiao-fei Su, Jian-hua Ma
Diabetes Therapy.2016; 7(4): 743.     CrossRef